Timothy P. Clackson - 11 Nov 2022 Form 4 Insider Report for Theseus Pharmaceuticals, Inc.

Role: President and CEO, Director
Signature: /s/ Bradford Dahms - Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 11 Nov 2022
Net transactions value: +$16,995
Form type: 4
Filing time: 14 Nov 2022, 15:12:56 UTC
Previous filing: 14 Oct 2022
Next filing: 21 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	THRX	Common Stock	Purchase	$16,995	+2,500	+0.72%	$6.80	351,030	11 Nov 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price of shares purchased. These shares were purchased in multiple transaction at prices ranging from $6.595 to $6.807, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

Content

The price reported is a weighted average price of shares purchased. These shares were purchased in multiple transaction at prices ranging from $6.595 to $6.807, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.